Glenn Markov, Ph.D.

Glenn did his PhD training in Genetics at Stanford University. His PhD focused on the epigenetics of reprogramming to the pluripotent stem cell phenotype. His interest in aging began with a lab rotation in Stuart Kim's lab where his project was to analyze the genomes of supercentenarians to find rare, high-impact genetic variants that contribute to health and longevity. Glenn co-founded Rejuvenation Technologies with John Ramunas and Professor Helen Blau in 2018 to focus on developing telomerase mRNA as a therapeutic for extending telomeres for aging and age-related disease.